JP2012521745A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521745A5 JP2012521745A5 JP2012501093A JP2012501093A JP2012521745A5 JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5 JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- mitochondrial fusion
- mammal
- acid sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2009/000351 WO2009117811A1 (en) | 2008-03-28 | 2009-03-27 | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| CAPCT/CA2009/000351 | 2009-03-27 | ||
| PCT/CA2010/000423 WO2010115261A1 (en) | 2009-03-27 | 2010-03-29 | Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012521745A JP2012521745A (ja) | 2012-09-20 |
| JP2012521745A5 true JP2012521745A5 (enExample) | 2013-05-16 |
| JP5734947B2 JP5734947B2 (ja) | 2015-06-17 |
Family
ID=42937093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501093A Expired - Fee Related JP5734947B2 (ja) | 2009-03-27 | 2010-03-29 | 異常型ミトコンドリアdna、関連融合転写物および翻訳産物、並びにそのハイブリダイゼーションプローブ |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP2411522B1 (enExample) |
| JP (1) | JP5734947B2 (enExample) |
| KR (1) | KR101720555B1 (enExample) |
| AU (1) | AU2010234238B2 (enExample) |
| RU (1) | RU2011137486A (enExample) |
| WO (1) | WO2010115261A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107011428B (zh) | 2008-03-28 | 2022-02-25 | Mdna生命科学有限公司 | 异常线粒体dna、相关的融合转录物及其杂交探针 |
| TWI709188B (zh) | 2018-09-27 | 2020-11-01 | 財團法人工業技術研究院 | 基於機率融合的分類器、分類方法及分類系統 |
| CN113025633B (zh) * | 2019-12-09 | 2024-08-27 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US6218117B1 (en) * | 1998-06-15 | 2001-04-17 | Mitokor | Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios |
| US20030162174A1 (en) * | 2001-06-11 | 2003-08-28 | Sutherland John W. | Detecting nucleic acid deletion sequences |
| JP2005506057A (ja) * | 2001-06-11 | 2005-03-03 | 1304854 オンタリオ・リミテッド | 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列 |
| SG2014011837A (en) * | 2005-04-18 | 2014-04-28 | Mitomics Inc | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| ES2484044T3 (es) * | 2007-09-26 | 2014-08-08 | Mitomics Inc. | Deleción de 3,4 kb en el ADN mitocondrial para uso en la detección de cáncer |
| CN107011428B (zh) * | 2008-03-28 | 2022-02-25 | Mdna生命科学有限公司 | 异常线粒体dna、相关的融合转录物及其杂交探针 |
-
2010
- 2010-03-29 EP EP10761136.0A patent/EP2411522B1/en not_active Not-in-force
- 2010-03-29 WO PCT/CA2010/000423 patent/WO2010115261A1/en not_active Ceased
- 2010-03-29 RU RU2011137486/10A patent/RU2011137486A/ru not_active Application Discontinuation
- 2010-03-29 KR KR1020117025261A patent/KR101720555B1/ko not_active Expired - Fee Related
- 2010-03-29 AU AU2010234238A patent/AU2010234238B2/en not_active Ceased
- 2010-03-29 JP JP2012501093A patent/JP5734947B2/ja not_active Expired - Fee Related
- 2010-03-29 EP EP17188792.0A patent/EP3272871B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015533788A5 (enExample) | ||
| Yamashita et al. | Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis | |
| US10705089B2 (en) | Methods and kits for the diagnosis of cancer | |
| JP6715770B2 (ja) | モノクローナル抗tk1抗体 | |
| RU2014108048A (ru) | Способ обнаружения рака поджелудочной железы | |
| JP2018042573A5 (enExample) | ||
| JO3812B1 (ar) | أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1) | |
| JP2014239695A5 (enExample) | ||
| BR112018070823A2 (pt) | anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno. | |
| JP2011512817A5 (enExample) | ||
| JP2011517341A (ja) | 小細胞肺癌バイオマーカーパネル | |
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| WO2009019365A3 (fr) | Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal | |
| JP2016026303A5 (enExample) | ||
| ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
| JP6815331B2 (ja) | 前立腺がんの分析のための組成物及び方法 | |
| JP2009539082A5 (enExample) | ||
| JP2017505436A5 (enExample) | ||
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| WO2008012362A3 (en) | New protein isoforms and uses thereof | |
| JP2012501318A5 (enExample) | ||
| JP2016536568A5 (enExample) | ||
| WO2010045495A3 (en) | Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof | |
| WO2009121024A3 (en) | Methods for detecting antibodies | |
| JP2018507254A5 (enExample) |